New lipid nanoparticle systems that deliver RNA effectively into muscles

Lipid nanoparticles (LNPs) are essential for RNA delivery, notably in the Pfizer-BioNTech and Moderna COVID-19 vaccines.

• LNPs encapsulate RNA using specialized lipids to facilitate its release within cells.
• Intramuscular administration promotes localized immune responses and minimizes overall toxicity.
• Current challenges include the need for cold storage, RNA instability, and potential immune reactions to certain lipids.
• Future developments may improve LNPs through AI-driven designs and hybrid systems for better stability and release control.
• LNPs have potential applications beyond COVID-19 vaccines, including in therapies for HIV, malaria, and personalized medicine.

Simplified